ResearcherUniversité de MontréalNo recent work listed

Audrey Hébert

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper

Papers 1

Phenylethynylbenzyl-modified biguanides inhibit pancreatic cancer tumor growth. Co-author DOI 10.1038/s41598-021-87993-3 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Maxime Parisotto · 1 shared paper, 2021 · strength 0.13
- Paper Phenylethynylbenzyl-modified biguanides inhibit pancreatic cancer tumor growth. DOI 10.1038/s41598-021-87993-3 ↗
Andreea R. Schmitzer · 1 shared paper, 2021 · strength 0.13
- Paper Phenylethynylbenzyl-modified biguanides inhibit pancreatic cancer tumor growth. DOI 10.1038/s41598-021-87993-3 ↗
Gerardo Ferbeyre · 1 shared paper, 2021 · strength 0.13
- Paper Phenylethynylbenzyl-modified biguanides inhibit pancreatic cancer tumor growth. DOI 10.1038/s41598-021-87993-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.